Drug Formulation Market to Surpass US$ 1.58 Tn Amid Increasing Demand for Oral Formulation Booming the Pharmaceutical Industry Growth in Coming Years | Future Market Insights, Inc.

East Asia drug formulation marker revenue valued to reach around US$ 320.7 Bn in 2032. Key Companies Profiled are- AstraZeneca plc., Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., AbbVie Inc.

NEWARK, Del., Nov. 10, 2022 /PRNewswire/ -- As per Future Market Insights, the global drug formulation market was valued at over US$ 1.50 Tn in 2021 and is expected to exhibit growth at a CAGR of 5.6% over the forecast period (2022-2032).

As pharmaceuticals enhance our quality of life, there is an increased demand for novel drugs formulation that would offer effective clinical care with a cost-effective manufacturing process. Biologics have proven to be an effective treatment option for chronic disease treatment. Pharmaceutical companies are being compelled by the rise of biosimilars to either innovate or lower prices to compete. This has been stimulating innovation in the field of biologics. As there are currently 37 approved biosimilars by the Food and Drug Administration (FDA). A significant portion of this expansion occurred in 2019 when the number of biosimilars that were approved increased by 65% and the number of such medicines that were made available in the United States increased by 157%.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15755 

However, manufacturers, payers, and providers anticipate that biosimilar competition will result in persistent price reductions, as demonstrated by the adoption of biosimilars in Europe over the past 13 years.

Manufacturers will be encouraged to cut the prices of their products as the number of treatment options for a particular sickness or condition increases that expects to drive the drug formulation market growth in coming years.

Key Takeaways from Market Study

• The oral formulation is expected to hold a 44.6% market value share by the end of 2032 and is expected to showcase growth at a CAGR growth of 6.0% over the forecast period.
• Based on various indications, central nervous systems disorders hold the highest market share of 14.1% of the market share in 2021 and are projected to dominate throughout the forecast period.
• In terms of end-user, the big pharma companies are expected to register a CAGR of 5.1% in upcoming years.
• North America is slated to be the leading region with a value share of 48.1% at the end of the forecast period.

"Growing prevalence of chronic disorders and Rising needs for novel drug formulation in the pharmaceutical sectors is expected to witness the growth of Drug Formulation Market over the forecast period," says an analyst of Future Market Insights.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-15755 

Market Competition

The drug formulation industry's pharmaceutical and biotech businesses are concentrating on leveraging market potential by implementing mergers and acquisitions strategies. The trend continues as a result of the effective marketing campaign of novel and innovative drug formulation portfolios following strategic partnerships, acquiring their place in the market. The key techniques employed by the manufacturers to extend their business units and customer bases in both developed and emerging economies include strategic collaborations, mergers and acquisitions, production capacity expansions, and expanding product sales.

For instance,

• The COVID-19 vaccine was developed by Pfizer with the assistance of Sanofi in 2021, and Bayer and CureVac formed a complex cooperation to distribute 160M doses of the vaccine by 2022.
• The German mRNA CDMO AmpTec was acquired by Millipore Sigma, the life science division of Merck KGaA. This strengthened offerings across the mRNA value chain, especially for MilliporeSigma, which already supplies lipids to Pfizer-BioNTech for their COVID-19 vaccines. Lipids are the main mode of delivery for mRNA therapeutics.

Key Market Segments Covered in Drug Formulation Industry Research

By Dosage Form:

• Oral formulations
• Tablets
• Immediate Release
• Modified Release
• Chewable
• Effervescent
• Capsules
• Hard Gelatin Capsules
• Softgel Capsules
• Others
• Powders & Granules
• Lozenges & Pastilles
• Gummies
• Others
• Parenteral formulations
• Solutions
• Suspensions
• Emulsions for injection or infusion
• Powders for injection or infusion
• Gels for injection implants
• Topical formulations
• Pastes
• Ointments and oils
• Creams, lotions, and foams.
• Gels, tinctures, and powders
• Sprays and patches
• Inhalation formulations
• Pressurized Metered Dose Inhaler
• Dry Powder Inhaler (DPI)
• Nebulizer

By Indication:

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Gastrointestinal Diseases
• Musculoskeletal Disorders
• Dermatological Disorders
• Other

By End User:

• Big pharma
• Small & Medium Size Pharma
• Biotech Companies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa (MEA)

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-15755 

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

Report Preview@ https://www.futuremarketinsights.com/reports/drug-formulation-market

Have a Look at Related Research Reports of Healthcare

Injectable Drug Delivery Market Size: Sales in the global Injectable Drug Delivery Market are slated to top US$ 41.5 Bn in 2022, projects Future Market Insights (FMI). Expanding at a healthy 8.9% CAGR, the market size is projected to total US$ 69.13 Bn by 2028

Therapeutic Drug Monitoring Market Share: The therapeutic drug monitoring market is projected to record a CAGR of 9.7% during the forecast period, up from US$ 1.5 Bn in 2020 to reach a valuation of US$ 2.9 Bn by 2026

Pharmaceutical Drug Delivery Market Trends: During the assessment period, the global Pharmaceutical Drug Delivery Market is expected to increase at a robust CAGR of 6%, from US$ 1600 Bn in 2021 to US$ 3000 Bn by 2032

Aseptic Formulation Processing Market Analysis: Aseptic formulation processing is the manipulation of sterile active pharmaceutical ingredient (APIs) or pharmaceutical product in a carefully controlled environment using aseptic technique in order to produce a sterile end product

Paediatric Wheelchairs Market Share: While there are a variety of products serving the needs of adult disability patients who need mobility support, there is also a niche market for paediatric wheelchairs that serve all the needs of the children who need assistance in mobility.

Healthcare IT Outsourcing Market Trends: The global healthcare IT outsourcing market is expected to reach a valuation of US$ 50,025.3 Million in 2022

Animal Healthcare Market Analysis: The animal healthcare market is valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027

Healthcare Interoperability Solutions Market Outlook: During the forecast period, the healthcare interoperability solutions market holds an average growth prospect with an anticipated CAGR of 14% to reach a valuation of US$ 5.5 Bn by 2026, from US$ 3.3 Bn in 2021

Pharmacy Refrigerators Market Analysis: The global pharmacy refrigerators market is estimated to be valued US$ 552.3 million in 2022, rising to US$ 1,027 million by 2032

Removable Partial Dentures Market Size: The global pharmacy refrigerators market is estimated to be valued US$ 552.3 million in 2022, rising to US$ 1,027 million by 2032

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.    
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA    
T: +1-845-579-5705    
For Sales Enquiries: [email protected]      
Browse Latest Market reports: https://www.futuremarketinsights.com/reports

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg

SOURCE Future Market Insights